Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1995-02-13
1997-02-25
Datlow, Philip I.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
A61K 3155
Patent
active
056058977
ABSTRACT:
Olanzapine, or an acid salt thereof, has pharmaceutical properties, and is of particular use in the treatment of disorders of the central nervous system. The compound has the following structure: ##STR1##
REFERENCES:
patent: 4115568 (1978-09-01), Chakrabarti et al.
patent: 4115574 (1978-09-01), Chakrabarti et al.
patent: 5229382 (1993-07-01), Chakrabarti
N. A. Moore et al., Journal of Pharmacology & Experimental Therapeutics, 262:2, pp. 545-551 (1992).
J. K. Chakrabarti, et al., J. Med. Chem., 23, pp. 878-884, (1980).
N. C. Tye et al., Second International Conference on Schizophrenia, Vancouver, B.C., Jul. 19-22, 1992.
C. M. Beasley, Jr. et al., Second International Conference on Schizophrenia, Vancouver, B.C., Jul. 19-22, 1992.
R. W. Fuller, et al., Research Communications in Chemical Pathology and Pharmacology, 77:1 pp. 87-93 (1992).
N. A. Moore, et al., Curr. Opin. Invest. Drugs, 2:4 pp. 281-293, (1993).
Beasley, Jr. Charles M.
Chakrabarti Jiban K.
Hotten Terrence M.
Tupper David E.
Boone David E.
Datlow Philip I.
Eli Lilly and Company
Lilly Industries Limited
Vorndran-Jones MaCharri
LandOfFree
2-methyl-thieno-benzodiazepine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-methyl-thieno-benzodiazepine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-methyl-thieno-benzodiazepine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1974099